5-Alpha Reductase

5-alpha reductase is an enzyme that converts testosterone to dihydrotestosterone (DHT), playing a crucial role in androgen metabolism. Inhibiting this enzyme helps reduce DHT levels, supporting prostate health and potentially slowing male pattern hair loss.

Origin & History

5-Alpha Reductase is a metabolic enzyme that converts testosterone into dihydrotestosterone (DHT), a more potent androgen. It is found in various tissues, including the prostate, skin, and liver, and plays a role in androgen metabolism.

Historical & Cultural Context

Identified in the mid-20th century, 5-alpha reductase has been studied for its role in androgen-related conditions.

Health Benefits

- Regulates androgen levels by converting testosterone to dihydrotestosterone (DHT), which helps maintain hormonal balance. - Supports prostate health by reducing DHT accumulation, lowering the risk of benign prostatic hyperplasia (BPH) by up to 35% in clinical studies. - Influences hair growth and scalp health by modulating DHT, a key factor in male and female pattern hair loss. - Enhances skin health by balancing sebum production, reducing acne flare-ups linked to excess androgens. - Promotes reproductive health by ensuring optimal androgen activity, which is essential for libido and fertility. - May support cardiovascular wellness by influencing androgen-mediated lipid metabolism. - Helps maintain muscle mass and bone density by regulating androgenic effects on tissues. - Modulates mood and cognitive function through its impact on neurosteroids derived from androgen metabolism.

How It Works

5-alpha reductase catalyzes the conversion of testosterone to dihydrotestosterone (DHT) using NADPH as a cofactor. The enzyme exists in two isoforms: Type I (primarily in skin and liver) and Type II (concentrated in prostate tissue). DHT binds to androgen receptors with 3-5 times greater affinity than testosterone, making it the primary mediator of androgenic effects in target tissues.

Scientific Research

Human trials and observational studies have explored its role in conditions like benign prostatic hyperplasia (BPH) and androgenic alopecia.

Clinical Summary

Large randomized controlled trials involving over 8,000 men demonstrated that 5-alpha reductase inhibitors reduce prostate volume by 18-28% and decrease BPH progression risk by 35-39%. Hair loss studies with 1,879 participants showed that finasteride (5mg daily) increased hair count by 10-12% over 2 years compared to placebo. Long-term safety data spans up to 7 years, though some studies report persistent sexual side effects in 2-4% of users. Evidence quality is high for prostate benefits and moderate for hair loss applications.

Nutritional Profile

- Enzyme involved in steroid metabolism.
- Converts testosterone to DHT.
- Influences androgenic activity in tissues.

Preparation & Dosage

No direct supplementation; modulation through lifestyle and dietary choices. Consult a healthcare provider before use.

Synergy & Pairings

Saw Palmetto, Zinc, Green tea extract

Safety & Interactions

Common side effects include decreased libido (3-5%), erectile dysfunction (2-4%), and reduced ejaculatory volume (1-3%). Post-finasteride syndrome, characterized by persistent sexual and neurological symptoms, affects approximately 1-2% of users even after discontinuation. The enzyme inhibitors may interact with testosterone replacement therapy and can cause birth defects in male fetuses, making them contraindicated during pregnancy. Regular monitoring of PSA levels is recommended as these compounds can artificially lower PSA readings by approximately 50%.